The Tumor Suppressor p53: From Structures to Drug Discovery
Andreas C. Joerger(Goethe University Frankfurt), Alan R. Fersht(MRC Laboratory of Molecular Biology)
Cited by 354
Related Papers
Thermodynamic stability of wild-type and mutant p53 core domain
|Proceedings of the National Academy of Sciences|1997|417
Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability
|Proceedings of the National Academy of Sciences|1998|253
Kinetic Instability of p53 Core Domain Mutants
|Journal of Biological Chemistry|2003|141
2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells
|Proceedings of the National Academy of Sciences|2016|119
Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization
|ACS Chemical Biology|2024|16